- Home
- / PHARMICELL
PHARMICELL
Stock Price
₩5 K
2024-10-29
Market Capitalization
₩300 B
2024-10-29
Revenue
₩56.2 B
FY, 2023
PHARMICELL Summary
Company Summary
- Overview
- PHARMICELL (파미셀) is a developer of biopharmaceuticals. It offers pharmaceutical and industrial materials, cosmetics, etc. The company provides cord blood stem cell storage, therapy, and other services.
- Type
- Public
- Status
- Active
- Founded
- 2002
- Website
- http://pharmicell.com
- Cybersecurity rating
- ESG rating
Table of Contents
PHARMICELL Financials
Summary Financials
- Revenue (Q3, 2025)
- ₩79.4B
- Gross profit (Q3, 2025)
- ₩38.7B
- Net income (Q3, 2025)
- ₩24.6B
- Cash (Q3, 2025)
- ₩19.2B
- EBIT (Q3, 2025)
- ₩25.1B
- Enterprise value
- $289.4B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026